Prestige Consumer Healthcare  logo
Prestige Consumer Healthcare PBH
$ 61.72 0.47%

Quarterly report 2025-Q3
added 11-06-2025

report update icon

Prestige Consumer Healthcare Income Statement 2011-2025 | PBH

Annual Income Statement Prestige Consumer Healthcare

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

4.12 B 3.5 B 3.03 B 3.05 B 2.83 B 2.06 B 1.53 B 1.56 B 3.04 B 3 B 2.05 B 1.73 B 1.36 B 854 M 578 M

Shares

49.7 M 49.8 M 49.9 M 50.3 M 50.2 M 50.7 M 52.1 M 53.1 M 53 M 52.8 M 52.2 M 51.6 M 50.6 M 50.3 M 50.1 M

Historical Prices

82.8 70.3 60.8 60.8 56.5 40 40.6 27.9 41.3 52.1 46.1 33.8 29.9 21.2 12.7

Net Income

215 M 209 M -82.3 M 205 M 165 M 142 M -35.8 M 340 M 69.4 M 99.9 M 78.3 M 72.6 M 65.5 M 37.2 M 29.2 M

Revenue

1.14 B 1.13 B 1.13 B 1.09 B 943 M 963 M 976 M 1.04 B 882 M 806 M 715 M 602 M 624 M 441 M 337 M

Cost of Revenue

503 M 501 M 502 M 466 M 396 M 411 M 420 M 465 M 382 M 339 M - - - - -

Gross Profit

634 M 624 M 625 M 621 M 547 M 552 M 556 M 577 M 500 M 467 M 406 M 340 M 347 M 227 M 171 M

Operating Income

337 M 342 M -22.4 M 330 M 297 M 291 M 67.5 M 215 M 206 M 260 M 208 M 189 M 192 M 103 M 76.1 M

Interest Expense

1.8 M 5.2 M -2.34 M -1.05 M 1.37 M -1.62 M -476 K 392 K -30 K - - - - - -

EBITDA

367 M 373 M 10.2 M 362 M 328 M 316 M 323 M 244 M 283 M 284 M 225 M 202 M 205 M 114 M 86 M

Operating Expenses

298 M 282 M 648 M 291 M 250 M 261 M 260 M 361 M 243 M 207 M 199 M 151 M 155 M 125 M 94.7 M

General and Administrative Expenses

108 M 106 M 107 M 107 M 83.1 M 89.1 M 89.8 M 185 M 89.1 M 72.4 M 81.3 M 48.5 M 51.5 M 56.7 M 42 M

All numbers in USD currency

Quarterly Income Statement Prestige Consumer Healthcare

2025-Q3 2025-Q2 2024-Q4 2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

49 M 49.5 M 49.6 M 49.7 M 49.9 M 49.7 M 49.7 M 49.8 M - 49.7 M 49.8 M 50.3 M - 50.3 M 50.2 M 50.2 M - 50.2 M 50.2 M 50.3 M 50.4 M 50.4 M 50.4 M 50.5 M 51.7 M 51.9 M 51.9 M 51.8 M 53.1 M 53.1 M 53.1 M 53 M 53 M 53 M 53 M 53 M 52.9 M 52.8 M 52.8 M 52.8 M 52.5 M 52.3 M 52.3 M 52.1 M 52 M 51.8 M 51.8 M 51.5 M 51.2 M 50.7 M 50.7 M 50.4 M 50.3 M 50.3 M 50.3 M 50.3 M 50.2 M

Net Income

42.2 M 47.5 M 61 M 54.4 M 49.1 M 53 M 53.6 M 53.3 M - 52 M 51 M 55.3 M - 50.2 M 153 M 103 M - 40.9 M 40.9 M 44.6 M 37 M 38.1 M 38.1 M 33.3 M 33.9 M 38.2 M 38.2 M 30.8 M -39.7 M 315 M 30.7 M 33.8 M 33.8 M 31.6 M 31.6 M 32.2 M -5.53 M 28 M 28 M 31.8 M 26.2 M 21.3 M 21.3 M 16.5 M 16.7 M 3.13 M 3.13 M 32.8 M 20.7 M 12.3 M 12.3 M 19.2 M 14.7 M 9.51 M 9.51 M 12.9 M 14.8 M

Revenue

274 M 250 M 290 M 284 M 267 M 283 M 286 M 279 M - 276 M 289 M 277 M - 274 M 820 M 545 M - 239 M 239 M 237 M 251 M 242 M 242 M 238 M 232 M 241 M 241 M 254 M 256 M 271 M 258 M 257 M 241 M 217 M 217 M 215 M 210 M 200 M 200 M 206 M 192 M 198 M 198 M 181 M 146 M 145 M 145 M 167 M 143 M 160 M 160 M 162 M 147 M 106 M 106 M 106 M 95.3 M

Cost of Revenue

123 M 109 M 129 M 126 M 121 M 125 M 126 M 125 M - 125 M 128 M 117 M - 119 M 348 M 229 M - 99.9 M 99.9 M 99.8 M 107 M 104 M 104 M 101 M 98.1 M 102 M 102 M 102 M 115 M 123 M 114 M 113 M 113 M 92.2 M 92.2 M 91.1 M 88 M - - - - - - - - - - - - - - - - - - - -

Gross Profit

152 M 140 M 161 M 157 M 146 M 158 M 160 M 155 M - 150 M 161 M 160 M - 155 M 472 M 317 M - 139 M 139 M 138 M 144 M 137 M 137 M 137 M 134 M 139 M 139 M 137 M 141 M 148 M 144 M 143 M 143 M 125 M 125 M 124 M 122 M 117 M 117 M 120 M 112 M 112 M 112 M 103 M 81.9 M 80.5 M 80.5 M 93.2 M 83 M 85 M 85 M 90.5 M 83.6 M 55.1 M 55.1 M 53.9 M 49.9 M

Operating Income

79.7 M 71.8 M 92 M 84.3 M 72 M 86.8 M 88.2 M 85.2 M - 87.2 M 84.4 M 87 M - 82.6 M 252 M 170 M - 73.4 M 73.4 M 72.9 M 73.9 M 76.4 M 76.4 M 69.3 M 71.5 M 77.5 M 77.5 M 70.9 M -23.1 M 83.9 M 75.7 M 79 M 79 M 69.3 M 69.3 M 71.1 M 12.2 M 62.6 M 62.6 M 69.9 M 62.5 M 57 M 57 M 46.5 M 42.8 M 40.5 M 40.5 M 53.8 M 49.4 M 46.7 M 46.7 M 51.2 M 43.8 M 23.6 M 23.6 M 29.4 M 27.2 M

Interest Expense

-501 K 224 K -353 K -395 K -496 K -682 K -229 K 1.24 M - -1.15 M -812 K -825 K - -177 K -565 K -388 K - 371 K 371 K 259 K -930 K 580 K 580 K -859 K -416 K -218 K -218 K -335 K 273 K -387 K 432 K 74 K 74 K -18.6 M -20.8 M -21.1 M -23.1 M -19.5 M -20.7 M -21.9 M -23.8 M -24.6 M -18.2 M -14.7 M -15 M -21.3 M -16.4 M -15.9 M -18.2 M -26.7 M -19.7 M -19.8 M -16.3 M -8.12 M -8.28 M -8.58 M -

EBITDA

84.2 M 79.4 M 96.2 M 89.1 M 80.2 M 91.7 M 93.2 M 92.7 M - 92.8 M 90 M 95.4 M - 88 M 276 M 185 M - 78.3 M 96.1 M 87.9 M 73.9 M 81.3 M 98.1 M 83.6 M 78.5 M 82.8 M 102 M 87.3 M -23.1 M 89.7 M 81.5 M 87.5 M 79 M 70.6 M 88 M 83.9 M 12.2 M 63.8 M 80.1 M 81.3 M 62.5 M 58 M 69 M 53.3 M 42.8 M 41.6 M 50.7 M 60.3 M 49.4 M 47.1 M 56.7 M 57.7 M 43.8 M 23.8 M 31.3 M 34.5 M 27.2 M

Operating Expenses

71.9 M 68.6 M 69.1 M 73 M 74 M 71.1 M 71.8 M 69.5 M - 63.2 M 76.6 M 73.1 M - 72.5 M 219 M 147 M - 65.4 M 65.4 M 64.8 M 70 M 61.1 M 61.1 M 67.4 M 62.6 M 61.7 M 61.7 M 66.5 M 164 M 63.8 M 68.4 M 64.5 M 64.5 M 55.3 M 55.3 M 52.9 M 109 M 54.1 M 54.1 M 50 M 49.7 M 54.8 M 54.8 M 56 M 39.1 M 40 M 40 M 39.5 M 33.6 M 38.3 M 38.3 M 39.4 M 39.8 M 31.5 M 31.5 M 24.5 M 22.6 M

General and Administrative Expenses

28 M 28.5 M 26.2 M 26.1 M 28.9 M 26 M 26 M 27.7 M - 26.5 M 26.4 M 26.7 M - 26 M 80.7 M 54.7 M - 21.4 M 21.4 M 20.4 M 23.6 M 21.3 M 21.3 M 22.5 M 21.7 M 20.5 M 20.5 M 24 M 22.2 M 20.8 M 22 M 20.4 M 20.4 M 22.1 M 22.1 M 18.8 M 19.5 M 18.1 M 18.1 M 16.5 M 17.6 M 19.5 M 19.5 M 27.1 M 17 M 12.1 M 12.1 M 11.6 M 11.6 M 11.4 M 11.4 M 12.6 M 16.2 M 13.7 M 13.7 M 8.86 M 9.85 M

All numbers in USD currency

The income statement is one of the three key financial reports of a company Prestige Consumer Healthcare (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:

  • How much revenue the company earned
  • How much it spent on production, personnel, marketing, taxes, etc.
  • What profit remained in the end

Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.

Features
  • The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
  • Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
  • A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.

Reports on the profits and losses of other stocks in the Medical distribution industry

Issuer Price % 24h Market Cap Country
AmerisourceBergen Corporation AmerisourceBergen Corporation
ABC
- -0.23 % $ 37.5 B usaUSA
Cardinal Health Cardinal Health
CAH
$ 199.57 0.71 % $ 48.1 B usaUSA
PPD, Inc. PPD, Inc.
PPD
- 0.13 % $ 16.6 B usaUSA
Henry Schein Henry Schein
HSIC
$ 77.33 1.03 % $ 9.8 B usaUSA
McKesson Corporation McKesson Corporation
MCK
$ 822.75 1.11 % $ 132 B usaUSA
Owens & Minor Owens & Minor
OMI
$ 3.01 -0.17 % $ 231 M usaUSA
Patterson Companies Patterson Companies
PDCO
- -0.87 % $ 3 B usaUSA